(a)    There is a technical advisory committee to the Program.

(b)    The purpose of the technical advisory committee is to:

(1)    Review requests for information from the Program under § 21–2A–06(b)(3), (4), (5), (6), (8), or (9) of this subtitle; and

(2)    Provide clinical guidance and interpretation to the Program regarding indications of possible misuse or abuse of a monitored prescription drug or a possible violation of law or a possible breach of professional standards by a prescriber or a dispenser under § 21–2A–06(c) and (d) of this subtitle.

(c)    The technical advisory committee consists of members appointed by the Secretary, including:

(1)    A board certified anesthesiologist licensed and practicing in the State, nominated by the Maryland Society of Anesthesiologists;

(2)    A certified addiction medicine specialist licensed and practicing in the State, nominated by the Maryland Society for Addiction Medicine;

(3)    A pharmacist licensed and practicing in the State;

(4)    A medical professional, licensed and practicing in the State, who is treating cancer patients;

(5)    A board certified physician specializing in the treatment of patients with pain, licensed and practicing in the State, nominated by the Maryland Society of Physical Medicine and Rehabilitation;

(6)    Two medical professionals, licensed and practicing in the State with expertise or experience in providing care for patients with substance–related or mental health disorders;

(7)    A dentist licensed and practicing in the State; and

(8)    A medical professional licensed and practicing in the State in the field of internal medicine or family practice.